Assess Gastrointestinal Blood Loss After Receiving Aspirin or Aspirin Plus Rivaroxaban in Healthy Adult Participants

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 5, 2023

Primary Completion Date

April 6, 2023

Study Completion Date

April 6, 2023

Conditions

Healthy Volunteer

Interventions

DRUG

Aspirin

Administered orally once per day (QD)

DRUG

rivaroxaban low dose

Administered orally twice per day (BID)

DRUG

rivaroxaban high dose

Administered orally QD

Trial Locations (1)

LabCorp CRU, Leeds

All Listed Sponsors

lead

Regeneron Pharmaceuticals

INDUSTRY